Crescendo Biologics
Crescendo Biologics selects current CFO Theodora Harold as new CEO
April 4, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Cambridge, Crescendo Biologics, Dr Peter Pack, Theo Harold, cfo
Cambridge, UK-based Crescendo Biologics have said current Chief Financial Officer (CFO) Theodora Harold will take over from Dr Peter Pack …
Takeda unveils three new discovery and development collaborations in immuno-oncology
January 4, 2019Medical Communications, Research and Development CAR-T, Crescendo Biologics, Memorial Sloan Kettering Cancer Center, Noile-Immune, Takeda, pharma
Takeda has revealed that it is set to bolster its novel immuno-oncology portfolio with three new research collaborations. The Japanese …
Takeda enters $790m cancer development deal
October 11, 2016Manufacturing and Production, Research and Development Cancer, Crescendo Biologics, Takeda, clinical partnership, humabody
Takeda and Crescendo Biologics have shaken hands on a $790 million deal to develop and commercialise cancer therapeutics using Crescendo’s …
Crescendo Biologics appoints Dr Barbara Fleck as head of intellectual property
February 2, 2016Research and Development Crescendo Biologics
Drug discovery and developer Crescendo Biologics has appointed Dr Barbara Fleck as head of intellectual property. Barbara Fleck, a European and …
Clive Dix appointed chairman of Crescendo Biologics
January 21, 2010Research and Development Crescendo Biologics, appointment, research and development
Cambridge, UK-based Crescendo Biologics has appointed Clive Dix as chairman. He will work closely with chief scientific officer Mike Romanos …
Latest content
FibroFind appoints Lee Borthwick as CEO
July 21, 2026
